Remedent, Inc.

REMI · OTC
Analyze with AI
3/31/2024
12/31/2023
9/30/2023
6/30/2023
Operating Activities
Net Income-$219$36-$30-$62
Dep. & Amort.$4$4$5$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$72$43-$59-$17
Other Non-Cash$51$10$130-$112
Operating Cash Flow-$92$93-$78-$53
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$68-$61$0$0
Net Chg. in Cash-$25$31-$35-$33
Supplemental Information
Beg. Cash$68$37$72$105
End Cash$43$68$37$72
Free Cash Flow-$92$93-$78-$53